Spotlight: How The FTC Could Hurt The Future Of Cancer Research

The Federal Trade Commission is taking action to block a biotech merger that will ultimately hinder the fight against cancer. Is it time to abolish this destructive agency? Steve Forbes on how this government body is doing more harm than good and on why the White House and Congress should act now. Steve Forbes shares his What’s Ahead Spotlights each Tuesday, Thursday and Friday.